RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Psychometric evaluation of the weekly version of the PTSD checklist for DSM-5
STRONG STAR Consortium and the Consortium to Alleviate PTSD (2025). Psychometric evaluation of the weekly version of the PTSD checklist for DSM-5. Assessment. https://doi.org/10.1177/10731911251321929
The posttraumatic stress disorder (PTSD) Checklist for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5; PCL-5) was designed and validated to track symptoms over the past month (PCL-5-M), yet an untested ad hoc weekly version (PCL-5-W) is commonly used to track changes during treatment. We used archival data of clinical trials for the treatment of PTSD in veterans to assess the construct validity of PCL-5-W. Both PCL-5-M and PCL-5-W were found to have configural measurement invariance across four consecutive administrations. The results also indicated at least partial metric and scalar invariance for each version. The reliability estimates of PCL-5-M and PCL-5-W at each time point were equivalent. However, we found a discrepancy with regard to concurrent validity; correlations with the nine-item Patient Health Questionnaire may be meaningfully different between PCL-5-M and PCL-5-W. Nevertheless, overall, the results suggest that PCL-5-W can be validly used to assess PTSD symptoms over time, but factor scores may need to be tracked alongside total scores to address validity concerns.